Adolescent polycystic ovary syndrome according to the international evidence-based guideline

被引:170
作者
Pena, Alexia S. [1 ,2 ]
Witchel, Selma F. [3 ]
Hoeger, Kathleen M. [4 ]
Oberfield, Sharon E. [5 ]
Vogiatzi, Maria G. [6 ]
Misso, Marie [6 ,7 ,8 ]
Garad, Rhonda [7 ,8 ]
Dabadghao, Preeti [9 ]
Teede, Helena [7 ,8 ]
机构
[1] Univ Adelaide, Discipline Paediat, Robinson Res Inst, 72 King William Rd, Adelaide, SA 5006, Australia
[2] Womens & Childrens Hosp, Endocrine Dept, 72 King William Rd, Adelaide, SA 5006, Australia
[3] Univ Pittsburgh, Dept Pediat, Div Pediat Endocrinol, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA
[4] Univ Rochester, Med Ctr, Dept OBGYN, Rochester, NY 14642 USA
[5] Columbia Univ, Irving Med Ctr, Div Pediat Endocrinol, New York, NY USA
[6] Univ Philadelphia, Perelman Sch Med, Childrens Hosp Philadelphia, Div Endocrinol, Philadelphia, PA USA
[7] Monash Univ, Sch Publ Hlth & Prevent Med, Monash Ctr Hlth Res & Implementat, Melbourne, Vic, Australia
[8] Monash Hlth, Melbourne, Vic, Australia
[9] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrinol, Lucknow, Uttar Pradesh, India
基金
澳大利亚国家健康与医学研究理事会;
关键词
Adolescents; Girls; Polycystic ovary syndrome; Evidence-based; Diagnosis; Treatment; ANTI-MULLERIAN HORMONE; RANDOMIZED CONTROLLED-TRIAL; LIFE-STYLE MODIFICATION; LOW-DOSE FINASTERIDE; BODY-MASS INDEX; QUALITY-OF-LIFE; MENSTRUAL-CYCLE; ORAL-CONTRACEPTIVES; ANXIETY SYMPTOMS; PREDICTIVE-VALUE;
D O I
10.1186/s12916-020-01516-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with adult diagnostic criteria. The international evidence-based PCOS Guideline aimed to promote accurate and timely diagnosis, to optimise consistent care, and to improve health outcomes for adolescents and women with PCOS. Methods International healthcare professionals, evidence synthesis teams and consumers informed the priorities, reviewed published data and synthesised the recommendations for the Guideline. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied to appraise the evidence quality and the feasibility, acceptability, cost, implementation and strength of the recommendations. Results This paper focuses on the specific adolescent PCOS Guideline recommendations. Specific criteria to improve diagnostic accuracy and avoid over diagnosis include: (1) irregular menstrual cycles defined according to years post-menarche; > 90 days for any one cycle (> 1 year post-menarche), cycles< 21 or > 45 days (> 1 to < 3 years post-menarche); cycles < 21 or > 35 days (> 3 years post-menarche) and primary amenorrhea by age 15 or > 3 years post-thelarche. Irregular menstrual cycles (< 1 year post-menarche) represent normal pubertal transition. (2) Hyperandrogenism defined as hirsutism, severe acne and/or biochemical hyperandrogenaemia confirmed using validated high-quality assays. (3) Pelvic ultrasound not recommended for diagnosis of PCOS within 8 years post menarche. (4) Anti-Mullerian hormone levels not recommended for PCOS diagnosis; and (5) exclusion of other disorders that mimic PCOS. For adolescents who have features of PCOS but do not meet diagnostic criteria an 'at risk' label can be considered with appropriate symptomatic treatment and regular re-evaluations. Menstrual cycle re-evaluation can occur over 3 years post menarche and where only menstrual irregularity or hyperandrogenism are present initially, evaluation with ultrasound can occur after 8 years post menarche. Screening for anxiety and depression is required and assessment of eating disorders warrants consideration. Available data endorse the benefits of healthy lifestyle interventions to prevent excess weight gain and should be recommended. For symptom management, the combined oral contraceptive pill and/or metformin may be beneficial. Conclusions Extensive international engagement accompanied by rigorous processes honed both diagnostic criteria and treatment recommendations for PCOS during adolescence.
引用
收藏
页数:16
相关论文
共 119 条
[1]   Metformin or Oral Contraceptives for Adolescents With Polycystic Ovarian Syndrome: A Meta-analysis [J].
Al Khalifah, Reem A. ;
Florez, Ivan D. ;
Dennis, Brittany ;
Thabane, Lehana ;
Bassilious, Ereny .
PEDIATRICS, 2016, 137 (05)
[2]  
Al-Zubeidi H, 2015, J PEDIATR ENDOCR MET, V28, P853, DOI 10.1515/jpem-2014-0283
[3]  
Allen HF, 2005, J PEDIATR ENDOCR MET, V18, P761
[4]  
Amiri Mania, 2014, J Reprod Infertil, V15, P205
[5]  
[Anonymous], 2018, INT EVIDENCE BASED G
[6]  
[Anonymous], 2016, QUICK REF CHART WHO
[7]  
[Anonymous], 2009, Natl Health Med Res Counc
[8]  
[Anonymous], 2018, TECHNICAL REPORT INT
[9]  
[Anonymous], 2007, NHMRC STAND PROC EXT
[10]   SERUM PREGNENOLONE, PROGESTERONE, 17-HYDROXYPROGESTERONE, TESTOSTERONE AND 5 ALPHA-DIHYDROTESTOSTERONE DURING FEMALE PUBERTY [J].
APTER, D ;
VIHKO, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 45 (05) :1039-1048